References
- E. Basar, B. Guntekin. A review of brain oscillations in cognitive disorders and the role of eurotransmitters. Brain Res vol 1235, pp. 172-193. 2008 https://doi.org/10.1016/j.brainres.2008.06.103
- C. P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, et al. Global prevalence of dementia: a Delphi consensus study. Lancet., vol. 17, pp. 366:2112-7. 2005 https://doi.org/10.1016/S0140-6736(05)67889-0
- C. M. Clark, C. DeCarli, D. Mungas, H. I. Chui, R. Higdon, J. Nunez, et al. Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Archives Neurology., vol 62, pp. 774-778. 2005 https://doi.org/10.1001/archneur.62.5.774
- H. Y. Lee, H. J. Kim, I. C. Im, J. S. Lee, "Correlation between the seoul neuropsychological screening battery of the pakinson's disease patient with mild cognitive impairment and change of the cerebral ventricle volume in the brain MRI" J. Korean Scociety Radiology. vol. 8, No. 5, August. 2014
- Ministy for Health, Welfare and Family Affairs,"Nationwide Study on the Prevalence of Dementia in Korean Elders", Ministy for Health, Welfare and Family Affairs, 2012
- National Health Insurance Service. Press Release. 2015. 09. 14.
- M. D. Greicius, G. Srivastava, A. L. Reiss, and V. Menon,"Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI.,"
- L. D. Wang, M. R. Catherine, Z. Abraham, R. Matthew, B. Jewell, B. A. Thomas, et. al. Alzheimet dissease family history impacts restiong state function connectivity. Process. National. Academy. Sci. U. S. A., vol. 101, no. 13, pp. 4637-42, Mar. 2004. https://doi.org/10.1073/pnas.0308627101
- D. Y. Lee, E. Fletcher, O. Martinez, M. Ortega, N. Zozulya J. Kim, J. Tran, M. Buonocore, O. Carmichael, and C. DeCarli, "Regional pattern of white matter microstructural changes in normal aging, MCI, and AD.," Neurology, vol. 73, no. 21, pp. 1722-8, Nov. 2009. https://doi.org/10.1212/WNL.0b013e3181c33afb
-
A. C. van Harten, P. J. Visser, Y. A. Pijnenburg, C. E. Teunissen, M. A. Blankenstein, P. Scheltens, et al. Cerebrospinal fluid
$A{\beta}$ 42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dementia., vol. 9, pp. 481-487. 2013 https://doi.org/10.1016/j.jalz.2012.08.004 - Y. S. Shim, Morris JC. Biomarkers predicting Alzheimer's disease in cognitively normal aging. J Clinical Neurology., vol. 7, pp. 60-68. 2011 https://doi.org/10.3988/jcn.2011.7.2.60
- A. M. Fagan, C. M. Roe, C. Xiong, M. A. Mintun, J. C. Morris, D. M. Holtzman. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Archives Neurology, vol. 64 pp. 343-349. 2007 https://doi.org/10.1001/archneur.64.3.noc60123
- G. Verdile, S. Fuller, C. S. Atwood, S. M. Laws, S. E. Gandy, R. N. Martins. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacology Research vol. 50, pp. 397-409. 2004 https://doi.org/10.1016/j.phrs.2003.12.028